Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Immunological Investigations|September 29, 2012
Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypothesesSamantha Solito, Laura Pinton, Vera Damuzzo, et al.
Frontiers in Immunology|August 15, 2020
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint BlockadeElisa Peranzoni, Vincenzo Ingangi, Elena Masetto, et al.
Annals of the New York Academy of Sciences|June 27, 2014
Myeloid-derived suppressor cell heterogeneity in human cancersSamantha Solito, Ilaria Marigo, Laura Pinton, et al.
Cytometry. Part B, Clinical Cytometry|November 27, 2014
Complexity and challenges in defining myeloid-derived suppressor cellsVera Damuzzo, Laura Pinton, Giacomo Desantis, et al.
Cytometry. Part B, Clinical Cytometry|December 16, 2014
Complexity and challenges in defining myeloid-derived suppressor cellsVera Damuzzo, Laura Pinton, Giacomo Desantis, et al.
Oncoimmunology|June 15, 2018
Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningiomaLaura Pinton, Samantha Solito, Elena Masetto, et al.
Current Protocols in Immunology|October 11, 2018
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In VivoSamantha Solito, Laura Pinton, Francesco De Sanctis, et al.
Frontiers in Immunology|November 8, 2023
The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumorsBeatrice Musca, Maria Giovanna Russo, Ada Tushe, et al.
Oncotarget|December 25, 2015
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppressionLaura Pinton, Samantha Solito, Vera Damuzzo, et al.
Biomaterials|May 3, 2016
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapyMaria Stella Sasso, Giovanna Lollo, Marion Pitorre, et al.
Pageof 2